Evaluation of the neuroprotective, anticonvulsant, and cognition-improvement effects of apigenin in temporal lobe epilepsy: Involvement of the mitochondrial apoptotic pathway.
Anticonvulsant
Apigenin
Cognition
Cytochrome c
Neuroprotection
Temporal lobe epilepsy
Journal
Iranian journal of basic medical sciences
ISSN: 2008-3866
Titre abrégé: Iran J Basic Med Sci
Pays: Iran
ID NLM: 101517966
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
entrez:
7
5
2020
pubmed:
7
5
2020
medline:
7
5
2020
Statut:
ppublish
Résumé
Cognitive deficit is a common problem in epilepsy. A major concern emergent from the use of antiepileptic drugs includes their side effects on learning and memory. Herbal medicine is considered a complementary and alternative therapy in epilepsy. Apigenin is a safe flavone with antioxidant properties. However, there is little information about the beneficial effect of apigenin on cognition in epilepsy. For evaluating the anticonvulsant effect of apigenin in the kainite temporal epilepsy model, apigenin was orally administered at 50 mg/kg for six days. Reference and working memory were examined via the Morris water maze and Y-maze task spontaneously. Results showed that apigenin had significant anticonvulsant activity ( These results suggest that apigenin restores memory impairment via anticonvulsant and neuroprotective activity.
Identifiants
pubmed: 32373296
doi: 10.22038/ijbms.2019.33892.8064
pmc: PMC7196342
doi:
Types de publication
Journal Article
Langues
eng
Pagination
752-758Références
J Cereb Blood Flow Metab. 2005 Dec;25(12):1557-72
pubmed: 15889042
Epilepsy Behav. 2009 Jan;14 Suppl 1:65-73
pubmed: 18796338
Prog Brain Res. 2002;135:95-110
pubmed: 12143373
Expert Opin Drug Metab Toxicol. 2017 Mar;13(3):323-330
pubmed: 27766890
Neuroscientist. 2010 Jun;16(3):253-75
pubmed: 20479472
J Biol Chem. 2004 Feb 6;279(6):4479-89
pubmed: 14602723
Eur J Pharmacol. 2015 Sep 5;762:72-81
pubmed: 26007643
Brain Res. 2000 Aug 25;874(2):123-30
pubmed: 10960596
Front Syst Neurosci. 2014 Apr 16;8:58
pubmed: 24795575
Sci Rep. 2016 Aug 12;6:31450
pubmed: 27514990
Brain. 2009 Oct;132(Pt 10):2822-30
pubmed: 19635728
Neurology. 2006 Oct 24;67(8):1383-9
pubmed: 17060564
Food Chem Toxicol. 2017 Nov;109(Pt 1):517-525
pubmed: 28963002
Molecules. 2013 Aug 19;18(8):9949-65
pubmed: 23966081
Epilepsy Res. 2006 Jan;68(1):63-7
pubmed: 16377148
Cardiovasc Toxicol. 2015 Jul;15(3):241-9
pubmed: 25377428
Neuropsychiatr Dis Treat. 2016 Oct 12;12:2605-2616
pubmed: 27789949
Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2887-99
pubmed: 24184743
Expert Opin Ther Pat. 2009 Apr;19(4):523-7
pubmed: 19441930
Mol Cancer Ther. 2006 Apr;5(4):843-52
pubmed: 16648554
Eur J Neurosci. 2007 Jun;25(12):3667-77
pubmed: 17610586
Epilepsia. 2007;48 Suppl 8:24-7
pubmed: 18329991
Life Sci. 2005 Feb 4;76(12):1367-79
pubmed: 15670616
Biol Pharm Bull. 2012;35(9):1440-6
pubmed: 22975493